Skip to main content
Premium Trial:

Request an Annual Quote

FDA Issues EUAs for COVID Molecular Tests From Access Medical, Drexel University

NEW YORK – Access Medical Laboratories and Drexel University College of Medicine each recently were issued Emergency Use Authorizations by the US Food and Drug Administration for COVID-19 molecular diagnostic tests to detect the SARS-CoV-2 virus.

The agency granted Access Medical an EUA on Wednesday for its Global Direct RT-PCR Test for the qualitative detection of SARS-CoV-2 nucleic acid in nasopharyngeal and anterior nasal swab specimens. The use of the test is limited to the company's CLIA-certified laboratory in Jupiter, Florida.

Meantime, the FDA granted EUA to Drexel's SARS-CoV-2 DUCoM-PDL Modified Tetracore Assay last week for the qualitative detection of SARS-CoV-2 nucleic acid in mid-turbinate nasal swab specimens. The test can be performed only at Drexel's CLIA-certified lab in Philadelphia.

According to the FDA, for both tests, nucleic acid is extracted, isolated, and purified then reverse transcribed into cDNA for PCR amplification followed by detection with an RT-PCR instrument.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.